This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Stock Market News for Aug 30, 2022
by Zacks Equity Research
U.S. stocks closed lower on Monday as investors struggled to regain their lost confidence from last week's selloff as they continued to react to remarks from Fed Chair Jerome Powell, who said the central bank will not go soft on its rate-hike policy till it is able to fully check inflation.
Is Most-Watched Stock Salesforce Inc. (CRM) Worth Betting on Now?
by Zacks Equity Research
Salesforce.com (CRM) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Salesforce (CRM) Q2 Earnings Beat, Stock Falls on Guidance Cut
by Zacks Equity Research
Accelerated digitalization, the rapid adoption of cloud-based solutions and strategic acquisitions result in Salesforce's (CRM) better-than-anticipated Q2 performance.
A Bottom Forming in Housing? Plus NVDA, CRM, SNOW Report Q2
by Mark Vickery
If we've come close to hitting bottom on housing, that suggests the return back upward should (soon?) follow.
Salesforce.com (CRM) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Salesforce.com (CRM) delivered earnings and revenue surprises of 16.67% and 0.34%, respectively, for the quarter ended July 2022. Do the numbers hold clues to what lies ahead for the stock?
Durable Goods Orders Remain Unchanged
by Zacks Equity Research
Durable Goods Orders Remain Unchanged.
Durable Goods Are Goldilocks; Pending Home Sales on Deck
by Mark Vickery
While there's nothing sexy about a 0.0% economic read on Durable Goods orders, it's actually fairly Goldilocks.
This Week's 5 Hot Tech Earnings Charts
by Tracey Ryniec
Earnings aren't over for big technology. NVIDIA and 4 other companies are out this week.
Should You Invest in the Global X Cloud Computing ETF (CLOU)?
by Zacks Equity Research
Sector ETF report for CLOU
Salesforce Q2 Preview: Can Shares Find New Life?
by Derek Lewis
Salesforce shares have lagged the S&P 500's remarkable rally over the last month, declining a marginal 0.4%.
Cloud Adoption, Buyouts to Aid Salesforce (CRM) Q2 Earnings
by Zacks Equity Research
Salesforce's (CRM) Q2 results are likely to reflect gains from acquisitions and partnerships along with the benefits of the solid demand for its solutions amid the accelerated digital transformation.
Salesforce (CRM) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Salesforce's (CRM) second-quarter fiscal 2023 performance is likely to have benefited from the robust demand environment as customers are undergoing a major digital transformation.
Salesforce Inc. (CRM) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Salesforce.com (CRM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Salesforce.com (CRM) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Salesforce.com (CRM) closed at $191.06, marking a +0.62% move from the previous day.
Is Invesco Dynamic Large Cap Growth ETF (PWB) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for PWB
Stock Market News for Aug 9, 2022
by Zacks Equity Research
Stocks failed to hold on to early gains on Monday and ended almost flat as investors anxiously await the consumer price index report for July this week that will help them gauge how aggressive the Fed might be in its rate-hike policy.
Salesforce.com (CRM) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Salesforce.com (CRM) closed at $189.75, marking a -0.22% move from the previous day.
Salesforce Inc. (CRM) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Salesforce.com (CRM) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Salesforce.com (CRM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Salesforce.com (CRM) closed the most recent trading day at $183.79, moving +0.44% from the previous trading session.
Microsoft (MSFT) Misses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Microsoft (MSFT) delivered earnings and revenue surprises of -2.19% and 0.86%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Investors Heavily Search Salesforce Inc. (CRM): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching Salesforce.com (CRM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The Zacks Analyst Blog Highlights Visa, Abbott Laboratories, Salesforce, Wells Fargo and Centene
by Zacks Equity Research
Visa, Abbott Laboratories, Salesforce, Wells Fargo and Centene are included in this Analyst Blog.
Top Research Reports for Visa, Abbott & Salesforce
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), Abbott Laboratories (ABT) and Salesforce, Inc. (CRM).
Stock Market News for Jul 21, 2022
by Zacks Equity Research
U.S. stocks closed higher on Wednesday, driven by a rally in tech stocks, while investors remained wary about surging inflation and tried to assess how much interest rate the Fed would hike in its upcoming meeting.
6 Reasons Why You Should Invest in Salesforce (CRM) Stock Now
by Zacks Equity Research
Salesforce (CRM) is one stock that investors can consider adding to their portfolio amid the current stock market volatilities.